Evidence map›Paper›PMID 38926750›Full record

ArticleActa neuropathologica communications2024

Pediatric central nervous system tumor with CIC::LEUTX fusion: a diagnostic challenge.

Yanghao Hou, Yanru Du, Juan Wang, Xinke Zhang, Xueyan Zhao, Xinyi Xian, Li Yuan, Haigang Li, Yu Wang, Shaoyan Xi and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta neuropathologica communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Yanghao Hou *Department of Pathology, Center for Molecular Medicine Testing, College of Basic Medicine, Chongqing Medical University, Chongqing, P. R. China.ORCID 0000-0003-1597-6658
Yanru Du *Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, P. R. China.
Juan Wang *Department of Pathology, Nanjing Brain Hospital, Nanjing, P. R. China.
Xinke ZhangDepartment of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Xueyan ZhaoDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, P. R. China.
Xinyi XianDepartment of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Li YuanDepartment of Pathology, Guangzhou Women and Children Medical Center, Guangzhou, P. R. China.
Haigang LiDepartment of Pathology, Sun Yat-sen Memorial Hospital, Guangzhou, P. R. China.
Yu WangDepartment of Pathology, Zhujiang Hospital of Southern Medical University, Zhujiang, P. R. China.
Shaoyan XiDepartment of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Guan HuangDepartment of Pathology, Longgang District Central Hospital of Shenzhen, Shenzhen, P. R. China.
Wenbiao ZhuDepartment of Pathology, Meizhou People's Hospital, Meizhou, P. R. China.
Juan WangDepartment of Pediatric tumor, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Jin ZhuDepartment of Pathology, Center for Molecular Medicine Testing, College of Basic Medicine, Chongqing Medical University, Chongqing, P. R. China.
Qiubo YuDepartment of Pathology, Center for Molecular Medicine Testing, College of Basic Medicine, Chongqing Medical University, Chongqing, P. R. China.
Youde CaoDepartment of Pathology, Center for Molecular Medicine Testing, College of Basic Medicine, Chongqing Medical University, Chongqing, P. R. China.
JingXian WuDepartment of Pathology, Center for Molecular Medicine Testing, College of Basic Medicine, Chongqing Medical University, Chongqing, P. R. China.
Jing ZengDepartment of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China. zengjing@sysucc.org.cn.
Gehong DongDepartment of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, P. R. China. 13520157603@126.com.
Wanming HuDepartment of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China. huwm@sysucc.org.cn.ORCID 0000-0002-3632-1258

Funding

Guangzhou Municipal Science and Technology Project 202201011328National Natural Science Foundation of China 82102877Natural Science Foundation of Tianjin Municipal Science and Technology Commission CSTB2023NSCQ-BHX0105
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Central Nervous System NeoplasmsChildFemaleHumansMaleOncogene Proteins, FusionRepressor ProteinsCIC protein, humanOncogene Proteins, FusionRepressor Proteins

Identifiers

PMID38926750
PMCPMC11210039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.